Trial
NCT01095250
Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Uveitis
Intervention
AIN457
Why stopped
Terminated: Study in Behcet's disease with mostly active uveitis did not meet its primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-03